PROTAGONIST THERAPEUTICS INC
PTGXNASDAQ🏆 #790 by market capEarnings Nov 5US Equity
$148.26▼ $1.66 (−1.12%)
Pre-market · at close1h—
24h▼ 1.1%
7d▲ 7.8%
14d▲ 11.7%
30d▲ 14.3%
1y▲ 171.9%
🏦Market Cap
$9.53B
Small Cap
📈Revenue Growth (YoY)
+34.8%
High Growth
📊Gross Margin
—
💵FCF Margin
77.6%
Strong
⚖️P/S Ratio
33.9x
Expensive
Otter Score
42
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
2.29
Expected
2.27
beat
+0.90%
YoY +516.40%
Revenue
Actual
$213.47M
Expected
$212.03M
beat
+0.70%
YoY +3749.20%
Consensus estimates
Recent quarters
Q3 2026
2.29
beat
Q2 2026
0.05
beat
Q1 2026
-0.69
miss
Q4 2025
-0.62
miss